Search results
Kenyan media ‘under attack’ by police in protests
Semafor· 1 day agoBut Gaitho, however, insisted that the police were targeting him. The police have also often fired teargas directly at reporters covering the protests...
In the face of extreme, fluctuating weather, developing climate-resilient wheat a daunting challenge
Scroll· 7 hours agoThe year 2022 saw the hottest March in India since observed record-keeping started in 1901, with temperatures exceeding the normal by 4 degrees celsius to 6 degrees celsius in many parts. In ...
This Bill Purports to Protect Kids from Big Tech. For LGBTQ+ Youth, It’s a Grave Danger
them· 6 days agoThe number-one book targeted for censorship is a graphic novel memoir about gender identity. This...
Records fall as heat wave grips Utah
Deseret News· 7 days agoNo smoking near vegetation or outside of a developed recreation site, personal vehicle or building. No shooting of exploding targets or tracer...
Revolution sets sights on Phase III trial for pan-RAS inhibitor
Clinical Trials Arena· 2 days agoKRAS is a gene that provides instructions for making a protein called K-Ras, which is part of the...
Mahrang Baloch urges united front against Pakistan's oppression of Baloch people - Times of India
The Times of India· 11 hours agoAnnounced earlier this month, the Baloch National Gathering (BNG) is intended to unite the Baloch...
Rights group finds Hamas militants committed war crimes during Oct attack
Business Standard India· 2 days agoHamas-led armed groups committed numerous war crimes during the Oct. 7 attack on southern Israel...
Explainer: How is the apparel sector affected now CSDDD is here?
Just Style· 13 hours agoThe first phase of implementing the Corporate Sustainability Due Diligence Directive (CSDDD) could...
Charlotte stun Cincinnati with two goals in two minutes
OneFootball· 5 days agoFC Cincinnati looked nearly impenetrable against Inter Miami, but tonight, they have shown they are,...
Cytonics begins Phase I trial of new therapy to treat knee osteoarthritis
Clinical Trials Arena· 2 days agoThe first-in-human study aims to evaluate CYT-108, a recombinant protein designed to inhibit...
